. 2018 Jun 7;9:2207. doi: 10.1038/s41467-018-04442-y

Table 2.

Anti-ZIKV activity of individual (n = 10) SE samples and pooled SE

		IC₅₀ [% ±SD] average	IC₅₀ [%] pooled SE	IC₅₀ [%] Min.	IC₅₀ [%] Max.
ZIKV GWUH	Cell treat.	0.74 ± 0.18	0.67	0.49	0.98
ZIKV GWUH	Virion treat.	1.02 ± 0.33	0.71	0.65	1.84
ZIKV MR766	Cell treat.	0.84 ± 0.11	0.76	0.71	1.11
ZIKV MR766	Virion treat.	1.00 ± 0.25	0.92	0.68	1.39

Shown are IC₅₀ values derived from experiments shown in Fig. 4a, b and Supplementary Fig. 7a, b. Average IC₅₀ values represent means derived from the 10 donors; Min., lowest IC₅₀ measured; Max., highest IC₅₀ measured